Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron for Brown Fat Stimulation in Lean and Obese Adults
NCT02354807Phase 2Unknown
- Sponsor
- Otto Muzik
- Start
- Oct 2015
- Primary completion
- Oct 2017
- Countries
- 1
01
Overview
Phase 2, open-label trial of mirabegron in obesity, sponsored by Otto Muzik. Primary endpoint: Standardized Uptake Value at 4 hours. Status: unknown.
02
Drugs
mirabegron
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02354807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02354807.